Detalles de la búsqueda
1.
Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT.
Blood
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657278
2.
RAS/RAFlandscape in monoclonal plasma cell conditions.
Blood
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643494
3.
Potential future direction of measurable residual disease evaluation in multiple myeloma.
Blood
; 142(18): 1509-1517, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37471603
4.
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis.
Blood
; 141(22): 2771-2779, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36827620
5.
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Blood
; 141(11): 1308-1315, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375118
6.
Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Cancer
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758817
7.
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581695
8.
Impact of elranatamab on quality of life: Patient-reported outcomes from MagnetisMM-3.
Br J Haematol
; 204(5): 1801-1810, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420657
9.
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Br J Haematol
; 204(1): 250-259, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37784256
10.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122385
11.
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Blood
; 139(17): 2666-2672, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35171994
12.
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis.
Haematologica
; 109(2): 604-616, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584290
13.
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450525
14.
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Am J Hematol
; 99(3): 360-369, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165072
15.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654658
16.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414019
17.
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.
Cancer
; 129(17): 2645-2654, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269074
18.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
19.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
20.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
N Engl J Med
; 382(19): 1800-1810, 2020 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32320566